Terms: = Prostate cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130
39 results:
1. Involvement of Macrophages in Proliferation of prostate cancer Cells Infected with Trichomonas vaginalis.
Kim KS; Moon HS; Kim SS; Ryu JS
Korean J Parasitol; 2021 Dec; 59(6):557-564. PubMed ID: 34974662
[TBL] [Abstract] [Full Text] [Related]
2. Proliferation of Mouse prostate cancer Cells Inflamed by Trichomonas vaginalis.
Kim SS; Kim KS; Han IH; Kim Y; Bang SS; Kim JH; Kim YS; Choi SY; Ryu JS
Korean J Parasitol; 2021 Dec; 59(6):547-556. PubMed ID: 34974661
[TBL] [Abstract] [Full Text] [Related]
3. Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study.
Fantone S; Tossetta G; Montironi R; Senzacqua M; Marzioni D; Mazzucchelli R
Eur J Histochem; 2020 Oct; 64(4):. PubMed ID: 33131268
[TBL] [Abstract] [Full Text] [Related]
4. Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer.
Lu T; Tang J; Shrestha B; Heath BR; Hong L; Lei YL; Ljungman M; Neamati N
Theranostics; 2020; 10(15):6959-6976. PubMed ID: 32550915
[TBL] [Abstract] [Full Text] [Related]
5. SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis.
Liu S; Li X; Lin Z; Su L; Yan S; Zhao B; Miao J
Cancer Lett; 2018 Mar; 416():11-23. PubMed ID: 29247827
[TBL] [Abstract] [Full Text] [Related]
6. Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in cancer: Challenges and Opportunities.
Kampan NC; Xiang SD; McNally OM; Stephens AN; Quinn MA; Plebanski M
Curr Med Chem; 2018; 25(36):4785-4806. PubMed ID: 28707587
[TBL] [Abstract] [Full Text] [Related]
7. Expression of several cytokines in prostate cancer: Correlation with clinical variables of patients. Relationship with biochemical progression of the malignance.
Torrealba N; Rodríguez-Berriguete G; Fraile B; Olmedilla G; Martínez-Onsurbe P; Guil-Cid M; Paniagua R; Royuela M
Cytokine; 2017 Jan; 89():105-115. PubMed ID: 27527810
[TBL] [Abstract] [Full Text] [Related]
8. SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in prostate cancer Cells.
Handle F; Erb HH; Luef B; Hoefer J; Dietrich D; Parson W; Kristiansen G; Santer FR; Culig Z
Mol Cancer Res; 2016 Jun; 14(6):574-85. PubMed ID: 27053681
[TBL] [Abstract] [Full Text] [Related]
9. Control of gp130 expression by the mitogen-activated protein kinase ERK2.
Bonito NA; Drechsler J; Stoecker S; Carmo CR; Seckl MJ; Hermanns HM; Costa-Pereira AP
Oncogene; 2014 Apr; 33(17):2255-63. PubMed ID: 23686311
[TBL] [Abstract] [Full Text] [Related]
10. Interleukin-27 expression modifies prostate cancer cell crosstalk with bone and immune cells in vitro.
Zolochevska O; Diaz-Quiñones AO; Ellis J; Figueiredo ML
J Cell Physiol; 2013 May; 228(5):1127-36. PubMed ID: 23086758
[TBL] [Abstract] [Full Text] [Related]
11. LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signaling.
Ge D; Gao AC; Zhang Q; Liu S; Xue Y; You Z
Prostate; 2012 Sep; 72(12):1306-16. PubMed ID: 22213096
[TBL] [Abstract] [Full Text] [Related]
12. Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent manner.
Shariat SF; Chromecki TF; Hoefer J; Barbieri CE; Scherr DS; Karakiewicz PI; Roehrborn CG; Montorsi F; Culig Z; Cavarretta IT
J Urol; 2011 Nov; 186(5):2107-14. PubMed ID: 21944124
[TBL] [Abstract] [Full Text] [Related]
13. Genetic polymorphisms in inflammation pathway genes and prostate cancer risk.
Kwon EM; Salinas CA; Kolb S; Fu R; Feng Z; Stanford JL; Ostrander EA
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):923-33. PubMed ID: 21430300
[TBL] [Abstract] [Full Text] [Related]
14. Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma.
Hafeez BB; Zhong W; Weichert J; Dreckschmidt NE; Jamal MS; Verma AK
Cancer Res; 2011 Mar; 71(6):2318-27. PubMed ID: 21406403
[TBL] [Abstract] [Full Text] [Related]
15. Relationship between IL-6/ERK and NF-κB: a study in normal and pathological human prostate gland.
Rodríguez-Berriguete G; Prieto A; Fraile B; Bouraoui Y; de Bethencourt FR; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M
Eur Cytokine Netw; 2010 Dec; 21(4):241-50. PubMed ID: 21081304
[TBL] [Abstract] [Full Text] [Related]
16. A cell-permeable Stat3 SH2 domain mimetic inhibits Stat3 activation and induces antitumor cell effects in vitro.
Zhao W; Jaganathan S; Turkson J
J Biol Chem; 2010 Nov; 285(46):35855-65. PubMed ID: 20807764
[TBL] [Abstract] [Full Text] [Related]
17. Interleukin-6 regulates androgen synthesis in prostate cancer cells.
Chun JY; Nadiminty N; Dutt S; Lou W; Yang JC; Kung HJ; Evans CP; Gao AC
Clin Cancer Res; 2009 Aug; 15(15):4815-22. PubMed ID: 19638459
[TBL] [Abstract] [Full Text] [Related]
18. The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
Zoubeidi A; Rocha J; Zouanat FZ; Hamel L; Scarlata E; Aprikian AG; Chevalier S
Mol Cancer Res; 2009 Jan; 7(1):142-55. PubMed ID: 19147545
[TBL] [Abstract] [Full Text] [Related]
19. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention.
Crispen PL; Uzzo RG; Golovine K; Makhov P; Pollack A; Horwitz EM; Greenberg RE; Kolenko VM
Prostate; 2007 May; 67(6):582-90. PubMed ID: 17262802
[TBL] [Abstract] [Full Text] [Related]
20. Significance of autologous interleukin-6 production in the HA22T/VGH cell model of hepatocellular carcinoma.
Labbozzetta M; Notarbartolo M; Poma P; Giannitrapani L; Cervello M; Montalto G; D'Alessandro N
Ann N Y Acad Sci; 2006 Nov; 1089():268-75. PubMed ID: 17261774
[TBL] [Abstract] [Full Text] [Related]
[Next]
